Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- JD Health
- Jiangsu Hengrui Pharmaceuticals
Comparative performance (base 100)
Each asset is worth 100 at October 20, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | JD HealthStock | Jiangsu Hengrui PharmaceuticalsStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −38.9% | −28.4% |
| Annualized performanceAverage annual return that would produce the same total performance. | −39.3% | −28.7% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 42.3% | 32.9% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −54.1% | −36.3% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.97 | -0.96 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −4.3% | −3.3% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 122.99B HKD | 309.49B CNY |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 17.8 | 40.2 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 1.6 | 9.5 |
| Net marginShare of revenue retained as profit. | 7.9% | 24.9% |
| Return on equityReturn on equity (ROE). | 10.4% | 14.5% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +15.9% | +13.0% |
| Dividend yieldAnnual dividend relative to the share price. | None | 0.38% |
| Debt / equityFinancial debt relative to shareholders' equity. | 1% | 0% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- JD Health / Jiangsu Hengrui Pharmaceuticals0.41
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.